According to Mesoblast 's latest financial reports the company's total debt is $0.11 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-06-30 | $0.11 B | 8.97% |
2022-06-30 | $0.10 B | 1.34% |
2021-06-30 | $0.10 B | 6.22% |
2020-06-30 | $99.31 M | 22.18% |
2019-06-30 | $81.28 M | 36.85% |
2018-06-30 | $59.39 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | $0.8 M | -99.31% | Bahamas |
NRC Health
NRC | $36.68 M | -68.51% | ๐บ๐ธ USA |